99mTc-labeled monomeric and dimeric NGR peptides for SPECT imaging of CD13 receptor in tumor-bearing mice

Amino Acids

Volumn 44, Issue 5, 2013, Pages 1337-1345

  Ma, Wenhui ^a   Kang, Fei ^a   Wang, Zhe ^a   Yang, Weidong ^a   Li, Guiyu ^a   Ma, Xiaowei ^a   Li, Guoquan ^a   Chen, Kai ^c   Zhang, Yingqi ^b   Wang, Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

99mTc; Angiogenesis; CD13; NGR; SPECT

Indexed keywords

METALLOPROTEINASE; MICROSOMAL AMINOPEPTIDASE; NOGO 66 RECEPTOR; TECHNETIUM 99M;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIVER CELL CARCINOMA; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD13; CARCINOMA, HEPATOCELLULAR; DRUG STABILITY; HEP G2 CELLS; HT29 CELLS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

MUS;

EID: 84876672361     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1469-1     Document Type: Article

References (30)

1. Arap W, Pasqualini R et al (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279(5349):377-380 (Pubitemid 28063372)
2. Bhagwat SV, Lahdenranta J et al (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97(3):652-659 (Pubitemid 32113397)
3. Chen K, Conti PS (2010) Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev 62(11):1005-1022
4. Chen X, Tohme M et al (2004) Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging 3(2):96-104
5. Chen K, Sun X et al (2012) Evaluation of (6)(4)Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Mol Imaging Biol 14(1):96-105
6. Corti A, Ponzoni M (2004) Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs. Ann N Y Acad Sci 1028:104-112 (Pubitemid 40361814)
7. Corti A, Giovannini M et al (2010) Immunomodulatory agents with antivascular activity in the treatment of non-small cell lung cancer: focus on TLR9 Agonists, IMiDs and NGR-TNF. J Oncol 2010:732680
8. Curnis F, Arrigoni G et al (2002) Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res 62(3):867-874 (Pubitemid 34126966)
9. Dijkgraaf I, Yim CB et al (2011) PET imaging of alphavbeta(3) integrin expression in tumours with (6)(8)Ga-labelled mono-, di- and tetrameric RGD peptides. Eur J Nucl Med Mol Imaging 38(1):128-137
10. Gregorc V, Zucali PA et al (2010) Phase II study of asparagine-glycine- arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma. J Clin Oncol 28(15):2604-2611
11. Kessler T, Schwoppe C et al (2008) Generation of fusion proteins for selective occlusion of tumor vessels. Curr Drug Discov Technol 5(1):1-8 (Pubitemid 351364567)
12. Lei H, Cao P et al (2010) Expression and functional characterization of tumor-targeted fusion protein composed of NGR peptide and 15-kDa actin fragment. Appl Biochem Biotechnol 162(4):988-995
13. Lily Adar YS, Journoa Gal, David Ayelet (2011) Pro-apoptotic peptide-polymer conjugates to induce mitochondrial-dependent cell death. Polym Adv Technol 22:199-208
14. Meng J, Yan Z et al (2007) High-yield expression, purification and characterization of tumor-targeted IFN-alpha2a. Cytotherapy 9(1):60-68 (Pubitemid 46992968)
15. Ndinguri MW, Solipuram R et al (2009) Peptide targeting of platinum anti-cancer drugs. Bioconjug Chem 20(10):1869-1878
16. Negussie AH, Miller JL et al (2010) Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release 143(2):265-273
17. Oostendorp M, Douma K et al (2008) Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. Cancer Res 68(18):7676-7683
18. Pasqualini R, Koivunen E et al (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 60(3):722-727 (Pubitemid 30094573)
19. Petrovic N, Schacke W et al (2007) CD13/APN regulates endothelial invasion and filopodia formation. Blood 110(1):142-150 (Pubitemid 47026829)
20. Ruggiero A, Brader P et al (2010) Different strategies for reducing intestinal background radioactivity associated with imaging HSV1-tk expression using established radionucleoside probes. Mol Imaging 9(1):47-58
21. Santoro A, Rimassa L et al (2010) Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy. Eur J Cancer 46(15):2746-2752
22. Schwoppe C, Kessler T et al (2010) Tissue-factor fusion proteins induce occlusion of tumor vessels. Thromb Res 125(Suppl 2):S143-S150
23. van Hensbergen Y, Broxterman HJ et al (2004) Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts. Clin Cancer Res 10(3):1180-1191 (Pubitemid 38198920)
24. van Laarhoven HW, Fiedler W et al (2010) Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041). Clin Cancer Res 16(4):1315-1323
25. von Wallbrunn A, Waldeck J et al (2008) In vivo optical imaging of CD13/APN-expression in tumor xenografts. J Biomed Opt 13(1):011007
26. Wu Y, Zhang X et al (2005) Micropet imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med 46(10):1707-1718 (Pubitemid 46211595)
27. Yang YS, Zhang X et al (2006) Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. Nucl Med Biol 33(3):371-380
28. Yokoyama Y, Ramakrishnan S (2005) Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth. Cancer 104(2):321-331 (Pubitemid 40993259)
29. Zhang Z, Harada H et al (2005) Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging. Peptides 26(11):2182-2187 (Pubitemid 41584082)
30. Zhao BJ, Ke XY et al (2011) The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. J Drug Target 19(5):382-390